A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
Brexit Secretary David Davis has insisted EU opposition to UK proposals on the Irish border are no more than an ‘opening position’ in negoti
The pontiff was speaking as the leaders of North and South Korea prepare to meet in the Demilitarised Zone.
Judges have had to weigh up complicated issues in reaching their decisions.